C2 and COVID-19: Another transcriptomic analysis on the peripheral blood of COVID-19 patients revealed an upregulation of C1q and C2 expression in COVID-19 patients, high levels of C5aR1 expression were found in blood and pulmonary myeloid cells, and circulating levels of C5a were associated with the severity of COVID-19 (15).